TELMIKIND TRIO 12.5 TABLET is a combination of Chlorthalidone, Cilnidipine and Telmisartan which belongs to the group of medicines called Antihypertensive drugs.  It is used to manage essential hypertension in adults. High blood pressure that is not caused by any other condition is called essential hypertension. Symptoms of essential hypertension include early morning headaches, nosebleeds, irregular heartbeat, vision changes, buzzing in the ears, fatigue (feeling overtiredness), nausea, vomiting, confusion, anxiety, chest pain, and muscle tremors (shakiness).

TELMIKIND TRIO 12.5 TABLET is not recommended for use in patients with liver, kidney, and heart disease. TELMIKIND TRIO 12.5 TABLET is not recommended in early pregnancy and must not be taken when more than 3 months pregnant, as it may cause serious harm to the baby if used after 3 months of pregnancy. TELMIKIND TRIO 12.5 TABLET is not suitable for use by breastfeeding women. TELMIKIND TRIO 12.5 TABLET is not recommended for use in children and adolescents (under 18 years of age). Consult your doctor before taking this medicine.

TELMIKIND TRIO 12.5 TABLET and it should be used with caution in elderly patients. The most common side effects of taking TELMIKIND TRIO 12.5 TABLET are dizziness, nausea, headache, constipation, fever, and chills. Consult your doctor if the above-mentioned symptoms are not improving.